Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature

Background: Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumour of the infancy and of the first decade of life. It is locally aggressive and potentially life threatening when associated to consumptive coagulopathy, known as Kasabach-Merritt syndrome (KMS). No consensus or guideline for t...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Chinello, Daniela Di Carlo, Francesca Olivieri, Rita Balter, Massimiliano De Bortoli, Virginia Vitale, Ada Zaccaron, Elisa Bonetti, Alice Parisi, Simone Cesaro
Format: Article
Language:English
Published: PAGEPress Publications 2018-07-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/3450
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846096429920026624
author Matteo Chinello
Daniela Di Carlo
Francesca Olivieri
Rita Balter
Massimiliano De Bortoli
Virginia Vitale
Ada Zaccaron
Elisa Bonetti
Alice Parisi
Simone Cesaro
author_facet Matteo Chinello
Daniela Di Carlo
Francesca Olivieri
Rita Balter
Massimiliano De Bortoli
Virginia Vitale
Ada Zaccaron
Elisa Bonetti
Alice Parisi
Simone Cesaro
author_sort Matteo Chinello
collection DOAJ
description Background: Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumour of the infancy and of the first decade of life. It is locally aggressive and potentially life threatening when associated to consumptive coagulopathy, known as Kasabach-Merritt syndrome (KMS). No consensus or guideline for the therapy has been reached because of the lack of prospective trials and the different standard care suggestions are based on retrospective case series. Case report: We report the case of a 9-month-old male with KHE and KMS in which the initial response, obtained with prednisone and vincristine, was subsequently consolidated and strengthened by long-term treatment with sirolimus, an mTOR inhibitor. A summary of the published data is presented as well. Conclusions: The inhibition of mTOR pathway represents the most important therapeutic innovation introduced in the last few years for KHE. Our case shows the effectiveness and good tolerance of long-term therapy with sirolimus. Keywords: Kaposiform Hemangioendothelioma, Kasabach-Merrit syndrome, sirolimus, prednisone, vincristine
format Article
id doaj-art-cc13d3b545d44e8d8ca250df330e3307
institution Kabale University
issn 2035-3006
language English
publishDate 2018-07-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-cc13d3b545d44e8d8ca250df330e33072025-01-02T06:46:49ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062018-07-01101e2018043e201804310.4084/mjhid.2018.0431766Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literatureMatteo Chinello0Daniela Di Carlo1Francesca Olivieri2Rita Balter3Massimiliano De Bortoli4Virginia Vitale5Ada Zaccaron6Elisa Bonetti7Alice Parisi8Simone Cesaro9Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyMother and Child Department, University of VeronaMother and Child Department, University of VeronaPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyDepartment of Pathological Anatomy, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, ItalyBackground: Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumour of the infancy and of the first decade of life. It is locally aggressive and potentially life threatening when associated to consumptive coagulopathy, known as Kasabach-Merritt syndrome (KMS). No consensus or guideline for the therapy has been reached because of the lack of prospective trials and the different standard care suggestions are based on retrospective case series. Case report: We report the case of a 9-month-old male with KHE and KMS in which the initial response, obtained with prednisone and vincristine, was subsequently consolidated and strengthened by long-term treatment with sirolimus, an mTOR inhibitor. A summary of the published data is presented as well. Conclusions: The inhibition of mTOR pathway represents the most important therapeutic innovation introduced in the last few years for KHE. Our case shows the effectiveness and good tolerance of long-term therapy with sirolimus. Keywords: Kaposiform Hemangioendothelioma, Kasabach-Merrit syndrome, sirolimus, prednisone, vincristinehttps://www.mjhid.org/index.php/mjhid/article/view/3450Kaposiform Hemangioendothelioma, Kasabach-Merrit syndrome, sirolimus, prednisone, vincristine
spellingShingle Matteo Chinello
Daniela Di Carlo
Francesca Olivieri
Rita Balter
Massimiliano De Bortoli
Virginia Vitale
Ada Zaccaron
Elisa Bonetti
Alice Parisi
Simone Cesaro
Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
Mediterranean Journal of Hematology and Infectious Diseases
Kaposiform Hemangioendothelioma, Kasabach-Merrit syndrome, sirolimus, prednisone, vincristine
title Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
title_full Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
title_fullStr Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
title_full_unstemmed Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
title_short Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
title_sort successful management of kaposiform hemangioendothelioma with long term sirolimus treatment a case report and review of the literature
topic Kaposiform Hemangioendothelioma, Kasabach-Merrit syndrome, sirolimus, prednisone, vincristine
url https://www.mjhid.org/index.php/mjhid/article/view/3450
work_keys_str_mv AT matteochinello successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT danieladicarlo successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT francescaolivieri successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT ritabalter successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT massimilianodebortoli successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT virginiavitale successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT adazaccaron successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT elisabonetti successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT aliceparisi successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature
AT simonecesaro successfulmanagementofkaposiformhemangioendotheliomawithlongtermsirolimustreatmentacasereportandreviewoftheliterature